Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
2002

Rare Allele Variants in Neuroblastoma Tumors

Sample size: 44 publication 10 minutes Evidence: moderate

Author Information

Author(s): Abel F, Sjöberg R-M, Ejeskär K, Krona C, Martinsson T

Primary Institution: Department of Clinical Genetics, Gothenburg University, Sahlgrenska University Hospital/East, Gothenburg, Sweden

Hypothesis

Could mutated CASP9 or DFFA be causative in the development of neuroblastoma tumors in childhood?

Conclusion

The study found rare allele variants in the DFFA gene in two neuroblastoma cases, suggesting a potential role in neuroblastoma genetics.

Supporting Evidence

  • Two rare allele variants were found in the DFFA gene in two out of 44 neuroblastoma tumors.
  • One case was hemizygous due to deletion of the more common allele.
  • DFF45 is expressed more in low-stage neuroblastoma tumors compared to high-stage tumors.

Takeaway

Researchers looked at genes related to cell death in children with a type of cancer called neuroblastoma and found some rare changes in one of those genes.

Methodology

DNA was extracted from frozen tumor samples of 44 Scandinavian patients and analyzed for mutations in CASP9 and DFFA genes.

Limitations

The study only analyzed a limited number of tumors and may not represent all neuroblastoma cases.

Participant Demographics

The study included 44 Scandinavian patients with neuroblastoma of various stages.

Digital Object Identifier (DOI)

10.1038/sj/bjc/6600111

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication